sorafenib has been researched along with chidamide in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (chidamide) | Trials (chidamide) | Recent Studies (post-2010) (chidamide) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 17 | 1 | 16 |
| Protein | Taxonomy | sorafenib (IC50) | chidamide (IC50) |
|---|---|---|---|
| Histone deacetylase 3 | Homo sapiens (human) | 1.6124 | |
| Acetylcholinesterase | Mus musculus (house mouse) | 0.167 | |
| Nicotinamide phosphoribosyltransferase | Homo sapiens (human) | 2.1 | |
| Histone deacetylase 4 | Homo sapiens (human) | 3.6835 | |
| Histone deacetylase 1 | Homo sapiens (human) | 0.876 | |
| Histone deacetylase 7 | Homo sapiens (human) | 3.6835 | |
| Histone deacetylase 2 | Homo sapiens (human) | 1.6254 | |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | 1.9255 | |
| Histone deacetylase 11 | Homo sapiens (human) | 2.1317 | |
| Histone deacetylase 8 | Homo sapiens (human) | 2.225 | |
| Histone deacetylase 6 | Homo sapiens (human) | 3.6835 | |
| Histone deacetylase 9 | Homo sapiens (human) | 3.6835 | |
| Histone deacetylase 5 | Homo sapiens (human) | 3.6835 | |
| Nuclear receptor corepressor 2 | Homo sapiens (human) | 0.33 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Cui, H; Geng, A; Li, H; Lu, T; Zhang, L; Zhu, Y | 1 |
| Abuo-Rahma, GEA; Badr, M; Bass, AKA; El-Zoghbi, MS; Mohamed, MFA; Nageeb, EM | 1 |
1 review(s) available for sorafenib and chidamide
| Article | Year |
|---|---|
Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.
Topics: Androgen Antagonists; Animals; Antineoplastic Agents; Benzimidazoles; Cyclic Nucleotide Phosphodiesterases, Type 5; Daunorubicin; Doxorubicin; fms-Like Tyrosine Kinase 3; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Molecular Targeted Therapy; Morpholines; Nicotinamide Phosphoribosyltransferase; Nitric Oxide; Pyrimidines; Quinazolines; Structure-Activity Relationship; Transcription Factors | 2021 |
1 other study(ies) available for sorafenib and chidamide
| Article | Year |
|---|---|
Discovery of novel phenoxybenzamide analogues as Raf/HDAC dual inhibitors.
Topics: Histone Deacetylase Inhibitors; Humans; Phenoxybenzamine; Structure-Activity Relationship | 2019 |